PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
02-Feb-2026 Brainomix Launches Award-Winning Next Generation Stroke AI Platform with Novel Net Water Uptake Technology at the International Stroke Conference (ISC) Brainomix
02-Feb-2026 Critical Manufacturing Appoints Paul Straeten as Vice President of Life Sciences Critical Manufacturing
02-Feb-2026 Ajinomoto CELLiST Korea Launches CELLiSTTM AAV Production Supplement 1 to Boost Gene Therapy Production Efficiency Ajinomoto CELLiST
02-Feb-2026 FLIR THERMAL CAMERAS HELP ECOLOGISTS USE TEMPERATURE TO MONITOR STRESS FLIR
02-Feb-2026 Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay Andrew Lloyd Associates
30-Jan-2026 Compound Management Market Set to Surge to USD 1,721.3 Million by 2033, Projects Analysts at Acumen Research And Consulting Acumen Research And Consulting
29-Jan-2026 Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation Beckman Coulter Life Sciences
29-Jan-2026 Nanologica AB (publ) Acquires Ardena Södertälje AB Nanologica AB
29-Jan-2026 The European Commission extended the Marketing Authorisation for Vueway® (gadopiclenol) in the European Union for use in pediatric patients under 2 years of age Bracco Imaging S.p.A.
29-Jan-2026 ViCentra Appoints Diabetes Commercialization Leader Reman McDonagh as Vice President, Global Marketing ViCentra
29-Jan-2026 Biocomposites launches SYNICEM™ spacers in Canada Biocomposites
29-Jan-2026 TECregen Appoints Drug Development Veteran Dr. Klaas P. Zuideveld as Chief Executive Officer to Lead Thymus Regeneration Platform into Clinical Development TECregen
29-Jan-2026 Four additional sites open for recruitment in Oncoinvent’s Phase 2 trial Oncoinvent
29-Jan-2026 ENA Respiratory Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections ENA Respiratory
29-Jan-2026 ENA Respiratory Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections ENA Respiratory
29-Jan-2026 TPIAO aprobado para una nueva indicación: progreso clínico de la trombopoyetina humana recombinante en el tratamiento de la trombocitopenia HK DengYue
29-Jan-2026 Matexcel Expands Its Enzymatic Hydrolysis of Biomass Service to Support Efficient Biomass Conversion Matexcel
28-Jan-2026 Kayentis and Ametris join forces to deliver integrated eCOA solution measuring and improving wearable technology adherence in clinical trials Andrew Lloyd Associates
28-Jan-2026 En Carta Diagnostics receives FDA Breakthrough Device Designation for EC Pocket Lyme test Andrew Lloyd Associates
27-Jan-2026 PPS announces Chameleon 2026 tactile visualisation platform Stone Junction